COVID jab maker BioNTech to build SE Asia manufacturing site
COVID jab maker BioNTech said Monday it would build a Southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of mRNA-based vaccines per year.
by ·
COVID jab maker BioNTech said Monday it would build a Southeast Asia headquarters and manufacturing site in Singapore to produce hundreds of millions of mRNA-based vaccines per year.
by · Published May 20, 2021
by · Published June 10, 2021
by · Published May 27, 2021